TQL-block for Laparoscopic Hemicolectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

December 5, 2020

Study Completion Date

January 3, 2021

Conditions
Postoperative Pain
Interventions
DRUG

Ropivacaine

30 mL ropivacaine 0,375% administered on each side as bilateral TQL blocks

DRUG

Acetaminophen

Every six hours postoperative, all patients are administered 1 g of acetaminophen.

DEVICE

Patient controlled analgesia

PCA-pump with IV-Morphine. 5 mg administered per bolus. Lock-out time and max. dosage standardized.

DRUG

Morphine

intravenously administered morphine via PCA-pump

DRUG

Saline

30 ml saline 0,375% administered on each side as bilateral TQL blocks

DIAGNOSTIC_TEST

Blood samples

On the day of surgery, postop day 1+2 and day 10-14, all patients will have blood samples taken for immunological analysis

BEHAVIORAL

Quality of recovery-15 questionaire

On the day of surgery, postop day 1+2 and day 10-14, all patients are asked to fill out a short questionaire.

DIAGNOSTIC_TEST

Orthostatic hypotension

Before surgery, and 3, 6 and 24 hours postop. All patients are tested for orthostatic hypotension.

Trial Locations (1)

4000

Zealand University Hospital, Department of Anaesthesiology, Roskilde

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT03570541 - TQL-block for Laparoscopic Hemicolectomy | Biotech Hunter | Biotech Hunter